Paris | More than three billion doses of COVID vaccine have been administered globally, according to an AFP tally at 9:00 GMT Tuesday from official sources.
Although the first billion was reached 20 weeks after the first mass vaccination campaigns began in December, and the second billion in 6 weeks, it took less than 4 weeks to reach this third billion.
About 40% of doses administered worldwide (1.2 billion) were received in China. At the bottom of the podium are India (329 million) and the United States (324 million).
But compared to the population of countries with more than one million inhabitants, vaccination champions are in the Middle East: the United Arab Emirates (153 doses per 100 inhabitants), Bahrain (124) and Israel (124). In these countries, about 60% of the population is fully immunized or exceeds them.
Chile (118 doses per 100 inhabitants), United Kingdom (113), Mongolia (111), Uruguay (110), Hungary (107), Qatar (107), USA (98). In these countries, about half of their population is fully immunized (from 46% to 54%).
As for the European Union, it has administered 357 million doses to 50% of its population. Fully vaccinated 32% of the residents of the quarter. Malta, the smallest country in the Union, is by far the most developed: over 70% of its population is fully vaccinated. In the most populous EU countries – Germany, France, Italy, Spain – the average is about a third of the population, with about a third of their population fully vaccinated.
While most poor countries have now started vaccination, mainly thanks to the Covax mechanism (WHO, the Gavi Alliance and the Cepi Coalition), COVID vaccination remains highly inequal with the introduction of ‘high income’ countries (in the sense of the World Bank) an average of 79 doses per 100 people, compared with a single dose in low-income countries.
Five countries have not yet launched their campaign: Tanzania, Burundi, Eritrea, Haiti and North Korea.
Despite the controversy that it has been about, the AstraZeneca / Oxford vaccine, which is administered in nearly 80% of countries and territories where vaccinations take place (at least 171 out of 216), is by far the most widely used vaccine in the world. competitors developed by Pfizer / BioNTech (at least 102.47%), Sinopharm and Moderna (at least 48 countries, 22%), Sputnik V (at least 41.19%), Johnson & Johnson (at least 31.14%) and Sinovac (at least 24.11%).